← Leaderboards
Cate Speake
Benaroya Research Inst At Virginia Mason
$2,553,265
Attributed
$4,758,329
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2020–25$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,758,329 · 5
By mechanism
R01$2,326,300 · 1
R21$1,279,936 · 1
U01$517,100 · 1
R03$348,200 · 1
R34$286,793 · 1
Top collaborators
- Jane Hoyt Buckner3 shared
- Dirk Homann2 shared
- Bernard Khor1 shared
- Richard Anthony Kozarek1 shared
Most similar at Benaroya Research Inst At Virginia Mason
Same institution · by research overlap
- Jane Hoyt Buckner$93,413,622
- S Alice Long$5,134,395
Others in their field
Other Emerging Leaders on “Research Personnel”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- Lynn Briscoe · Leidos Biomedical Research, Inc.$160,201,956
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$123,112,727
Research focus
Research PersonnelCohortFutureImmunologyResearch InstituteImmuneDiabetes MellitusSamplingData SetDesignImmunologicsDisease ProgressionPathway InteractionsInsightImmune ResponseInsulin-Dependent Diabetes MellitusResponseAutoantibodiesNatural HistoryMemberFrequenciesInsulin SecretionMeasurementPersons
Grant awards (9)
The KQ1 serum study: soluble biomarkers for T1D risk, development & progression$1,095,529
R01 · FY2025 · DK
Build to LEAD - Building partnerships to Link the Exposome to Autoimmune Disease (Administrative Supplement)$526,999
R21 · FY2025 · AR
Type 1 Diabetes in Acute Pancreatitis Consortium â Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D$517,100
U01 · FY2025 · DK · contact PI
Evaluating the role of high-dose influenza vaccine in people with Down syndrome under age 65$286,793
R34 · FY2025 · AI · contact PI
The KQ1 serum study: soluble biomarkers for T1D risk, development & progression$1,230,771
R01 · FY2024 · DK
Build to LEAD â Building partnerships to Link the Exposome to Autoimmune Disease$492,707
R21 · FY2023 · AR
Build to LEAD â Building partnerships to Link the Exposome to Autoimmune Disease (Admin Supp)$260,230
R21 · FY2023 · AR
Using B cell features to explain heterogeneity in the rate of T1D progression$174,100
R03 · FY2021 · DK · contact PI
Using B cell features to explain heterogeneity in the rate of T1D progression$174,100
R03 · FY2020 · DK · contact PI